Dr Noor Hisham: Health Ministry has begun Ivermectin trial for high-risk Covid-19 patients


KUALA LUMPUR (Bernama): The Health Ministry and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 of the ministry's hospitals.

Health director-general Tan Sri Dr Noor Hisham Abdullah said Ivermectin is a Food and Drug Administration (FDA) approved anti-parasitic drug widely used for treating several neglected tropical diseases, including onchocerciasis, strongyloidiasis and helminthiases, however, the evidence is inconclusive to recommend routine use of Ivermectin for Covid-19 patients.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Nation

Blacksmith to be charged for meat cleaver attack in drunken brawl in JB
Floods: Final group of evacuees in Sabah return home
Mandopop sensation G.E.M. thrills a full house crowd of more than 50,000 at Bukit Jalil National Stadium
No porcine DNA found in 'ham and cheese' sandwiches with misused halal logo, says Armizan
EPF must explain why its "sell low, buy high" of MAHB shares were so close together in time, resulting in losses, says Ayer Itam MP Dr Wee
Average RM4,500 per head: Large payouts tempt locals to smuggle undocumented migrants into country, says Immigration Dept
MACC nears completion of 'Ops Sky' probe
Warisan remains committed to Sabahans, not political alliances, says Shafie
Fisherman regrets not stopping Norshamira from meeting her killer at dark jetty
Teen dies after fall from condo

Others Also Read